FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a novel heliomycin derivative, containing from one to three aminoalkylamino groups corresponding to formula I, tautomeric forms or pharmaceutically acceptable salts thereof, having the ability to inhibit cell proliferation, as well as to a pharmaceutical composition and method of inhibiting tumor cell proliferation. In formula IZ1-Z3 are independently a hydroxy group, C1–6 alkoxy group or amino C2–6 alkylamino group, optionally substituted with C1–6 alkyl, Z4 is independently a hydroxy group or C1–6 alkoxy group. (I).
EFFECT: ability to inhibit cell proliferation.
10 cl, 20 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SEMI-SYNTHETIC DERIVATIVES OF HELIOMYCIN INHIBITING TUMOR GROWTH | 2016 |
|
RU2644780C2 |
SUBSTITUTED ISOXAZOLES, PHARMACEUTICAL COMPOSITIONS BASED THEREON HAVING ANTIVIRAL ACTIVITY, AND METHOD FOR USE THEREOF | 2018 |
|
RU2733945C2 |
ANTIBACTERIAL AGENTS BASED ON QUATERNARY AMMONIUM SALTS | 2014 |
|
RU2561281C1 |
PYRIDOXINE-BASED COMPOUNDS CAPABLE OF GLUCOKINASE ENZYME ACTIVATION | 2017 |
|
RU2644355C1 |
METHOD OF PRODUCING Α-DIAZOCARBONYL COMPOUNDS IN AQUEOUS MEDIUM | 2018 |
|
RU2686489C1 |
QUATERNARY AMMONIUM SALTS BASED ON DERIVATIVES OF VITAMIN B6 | 2015 |
|
RU2607522C1 |
USE OF SUBSTITUTED 2-(2-(4,4,6-TRIMETHYL-2-OXO-4N-PYRROLO[3,2,1-IJ]QUINOLINE-1(2H)-YLIDENE)HYDRAZINYL)THIAZOLE-4(5H)-ONES AS INHIBITORS OF BLOOD COAGULATION FACTORS XA AND XIA AND METHOD FOR THEIR PREPARATION | 2023 |
|
RU2819271C1 |
METHOD FOR OBTAINING SUBSTITUTED (E)-2-(3-(1H-PYRROL-2-YL)ALLYLIDENE)-1H-INDANE-1,3(2H)-DIONES, AND THEIR APPLICATION AS PHOTOSENSITIZERS FOR SOLAR BATTERIES | 2023 |
|
RU2812075C1 |
PYRIDOXINE DERIVATIVE-BASED BETA-ADRENERGIC BLOCKING AGENTS | 2014 |
|
RU2569900C1 |
METHOD FOR INHIBITING TUMOR CELLS WITH NEW DERIVATIVES OF 3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDE | 2020 |
|
RU2746395C1 |
Authors
Dates
2018-10-25—Published
2018-06-20—Filed